Mar 10

Leukocyte-rich PRP for Knee Osteoarthritis: Current Concepts. 

Osteoarthritis is one of the most debilitating degenerative conditions affecting more than a third of the population of active individuals over the age of 65. Upon onset of clinical manifestations, osteoarthritis (OA) may become increasingly destructive regarding disease progression with respect to the microenvironment. Investigations into the leukocyte concentration in PRP formulations and its effect on the healing process in OA has created some controversy in evidence-based practice. It is well known that the inflammatory phase is integral to the...

Jan 14

A meta analysis does not confirm hypothesis for Platelet-Rich Plasma (PRP) versus Hyaluronic Acid (HA) in Knee Osteoarthritis

Knee Osteoarthritis is the leading cause of degenerative joint disease leading to joint dysfunction and pain. Both, intra-articular injections of PRP and HA have demonstrated effective long-term clinical management of pain symptoms and improving functionality. In 2015, as systematic review was published opposing the application of HA to treat knee osteoarthritis. Researchers Wu et al were led to hypothesize that PRP may prove to be a better modality than HA in the treatment of knee osteoarthritis, and thus performed a...

Oct 11

TOBI 2018 Symposium Abstracts Published in Biologic Orthopedic Journal

On June 8-9, 2018, field leaders in orthopedics and regenerative medicine from around the world gathered to present new research, data, and best practices. These world-class physicians and surgeons lectured and debated on regenerative medicine topics such as PRP, bone marrow concentrate (BMC), lipoaspirate, spine, biologics in orthopedic surgery, sports medicine, and regulatory issues.The abstracts from those lectures are now published in Biologic Orthopedic Journal. Abstracts feature speakers including Allan Mishra, Freddie Fu, J. Peter Rubin, Jason Dragoo, James HC...